吲哚胺2,3-双加氧酶2(IDO2)重组蛋白-蛋白质/抗原/多肽-试剂-生物在线
吲哚胺2,3-双加氧酶2(IDO2)重组蛋白

吲哚胺2,3-双加氧酶2(IDO2)重组蛋白

商家询价

产品名称: 吲哚胺2,3-双加氧酶2(IDO2)重组蛋白

英文名称: Recombinant Indoleamine-2,3-Dioxygenase 2 (IDO2)

产品编号: YB252Ra013

产品价格: 0

产品产地: 中国/美国

品牌商标: 钰博生物/Ybscience

更新时间: 2023-08-17T10:29:50

使用范围: null

上海钰博生物科技有限公司
  • 联系人 : 陈环环
  • 地址 : 上海市沪闵路6088号龙之梦大厦8楼806室
  • 邮编 : 200612
  • 所在区域 : 上海
  • 电话 : 183****2235
  • 传真 : 021-60514606
  • 邮箱 : shybio@126.com

 吲哚胺2,3-双加氧酶2(IDO2)重组蛋白

YB252Ra013
Recombinant Indoleamine-2,3-Dioxygenase 2 (IDO2)
Organism Species: Mus musculus (Mouse)
Instruction manual
FOR IN VITRO USE AND RESEARCH USE ONLY
NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES
9th Edition (Revised in Jul, 2013)
吲哚胺2,3-双加氧酶2(IDO2)重组蛋白[ PROPERTIES ]
Residues: Thr84~Arg228 (Accession # Q8R0V5),
with N-terminal His-Tag.
Host: E. coli
Purity: >95%
Endotoxin Level: <1.0EU per 1μg
(determined by the LAL method).
Formulation: Supplied as lyophilized form in PBS,
pH7.4, containing 1mM DTT, 5% trehalose, 0.01%
sarcosyl and preservative.
吲哚胺2,3-双加氧酶2(IDO2)重组蛋白Predicted isoelectric point: 6.0
Predicted Molecular Mass: 17.7kDa
Applications: SDS-PAGE; WB; ELISA; IP.
(May be suitable for use in other assays to be determined by the end user.)
[ USAGE ]
Reconstitute in sterile PBS, pH7.2-pH7.4.
[ STORAGE AND STABILITY ]
Storage: Avoid repeated freeze/thaw cycles.
Store at 2-8oC for one month.
Aliquot and store at -80oC for 12 months.
Stability Test: The thermal stability is described by the loss rate of the target
protein. The loss rate was determined by accelerated thermal degradation test,
that is, incubate the protein at 37oC for 48h, and no obvious degradation and
precipitation were observed. (Referring from China Biological Products Standard,
which was calculated by the Arrhenius equation.) The loss of this protein is less
than 5% within the expiration date under appropriate storage condition.
吲哚胺2,3-双加氧酶2(IDO2)重组蛋白[ SEQUENCES ]
The target protein is fused with N-terminal His-Tag, its sequence is listed below.
MGHHHHHHSGSEF- TMGFVWQ EGEGQPQKVL PRSLAIPFVE VSRNLGLPPI LVHSDLVLTN
WTKRNPEGPL EISNLETIIS FPGGESLRGF ILVTVLVEKA AVPGLKALVQ GMEAIRQHSQ
DTLLEALQQL RLSIQDITRA LAQMHDYVDP DIFYSVIR
[ REFERENCES ]
1. Church D.M., et al. (2009) PLoS Biol. 7:E1000112-E1000112. 2. Ball H.J., et al. (2007) Gene 396:203-213. 3. Yuasa H.J., et al. (2007) J. Mol. Evol. 65:705-714. 4. Metz R., et al. (2007) Cancer Res. 67:7082-7087.